These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 28895944)

  • 21. Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer.
    Winter JM; Gildea DE; Andreas JP; Gatti DM; Williams KA; Lee M; Hu Y; Zhang S; ; Mullikin JC; Wolfsberg TG; McDonnell SK; Fogarty ZC; Larson MC; French AJ; Schaid DJ; Thibodeau SN; Churchill GA; Crawford NP
    Cell Syst; 2017 Jan; 4(1):31-45.e6. PubMed ID: 27916600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes.
    Bai L; Yang HH; Hu Y; Shukla A; Ha NH; Doran A; Faraji F; Goldberger N; Lee MP; Keane T; Hunter KW
    PLoS Genet; 2016 Apr; 12(4):e1005989. PubMed ID: 27074153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome engineering in zygotes with CRISPR/Cas9.
    Boroviak K; Doe B; Banerjee R; Yang F; Bradley A
    Genesis; 2016 Feb; 54(2):78-85. PubMed ID: 26742453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of temporal variation on design and analysis of mouse knockout phenotyping studies.
    Karp NA; Speak AO; White JK; Adams DJ; Hrabé de Angelis M; Hérault Y; Mott RF
    PLoS One; 2014; 9(10):e111239. PubMed ID: 25343444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression.
    Ferguson B; Ram R; Handoko HY; Mukhopadhyay P; Muller HK; Soyer HP; Morahan G; Walker GJ
    Oncogene; 2015 May; 34(22):2879-86. PubMed ID: 25088201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Origins of metastatic traits.
    Vanharanta S; Massagué J
    Cancer Cell; 2013 Oct; 24(4):410-21. PubMed ID: 24135279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.
    White JK; Gerdin AK; Karp NA; Ryder E; Buljan M; Bussell JN; Salisbury J; Clare S; Ingham NJ; Podrini C; Houghton R; Estabel J; Bottomley JR; Melvin DG; Sunter D; Adams NC; ; Tannahill D; Logan DW; Macarthur DG; Flint J; Mahajan VB; Tsang SH; Smyth I; Watt FM; Skarnes WC; Dougan G; Adams DJ; Ramirez-Solis R; Bradley A; Steel KP
    Cell; 2013 Jul; 154(2):452-64. PubMed ID: 23870131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A conditional knockout resource for the genome-wide study of mouse gene function.
    Skarnes WC; Rosen B; West AP; Koutsourakis M; Bushell W; Iyer V; Mujica AO; Thomas M; Harrow J; Cox T; Jackson D; Severin J; Biggs P; Fu J; Nefedov M; de Jong PJ; Stewart AF; Bradley A
    Nature; 2011 Jun; 474(7351):337-42. PubMed ID: 21677750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative data analysis: the simultaneous analysis of multiple data sets.
    Curran PJ; Hussong AM
    Psychol Methods; 2009 Jun; 14(2):81-100. PubMed ID: 19485623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer metastasis: building a framework.
    Gupta GP; Massagué J
    Cell; 2006 Nov; 127(4):679-95. PubMed ID: 17110329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells.
    Okada F; Kobayashi M; Tanaka H; Kobayashi T; Tazawa H; Iuchi Y; Onuma K; Hosokawa M; Dinauer MC; Hunt NH
    Am J Pathol; 2006 Jul; 169(1):294-302. PubMed ID: 16816381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency.
    Chambers AF; Naumov GN; Vantyghem SA; Tuck AB
    Breast Cancer Res; 2000; 2(6):400-7. PubMed ID: 11250733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells.
    Ogasawara K; Hida S; Azimi N; Tagaya Y; Sato T; Yokochi-Fukuda T; Waldmann TA; Taniguchi T; Taki S
    Nature; 1998 Feb; 391(6668):700-3. PubMed ID: 9490414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.
    Matsuyama T; Kimura T; Kitagawa M; Pfeffer K; Kawakami T; Watanabe N; Kündig TM; Amakawa R; Kishihara K; Wakeham A
    Cell; 1993 Oct; 75(1):83-97. PubMed ID: 8402903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological behavior of malignant melanoma cells correlated to their survival in vivo.
    Fidler IJ
    Cancer Res; 1975 Jan; 35(1):218-24. PubMed ID: 1109790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome wide in vivo mouse screen data from studies to assess host regulation of metastatic colonisation.
    van der Weyden L; Karp NA; Swiatkowska A; Adams DJ; Speak AO
    Sci Data; 2017 Sep; 4():170129. PubMed ID: 28895944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An attempt to isolate genes responsible for spontaneous and experimental metastasis in the mouse model.
    Ito A; Watabe K; Koma Y; Kitamura Y
    Histol Histopathol; 2002; 17(3):951-9. PubMed ID: 12168807
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.